IL6 and breast carcinoma: Treatment with a genotoxic drug combination (5-fluorouracil, doxorubicin, and cyclophosphamide) activated an NF-kappaB-IL6-dependent inflammatory signaling that imparted stemness to nonstem cancer cells, induced multidrug resistance in breast cancer [34].